Urinary Excretion of Melatonin and Association with Breast Cancer: Meta-Analysis and Review of the Literature
Open Access
- 30 May 2014
- journal article
- review article
- Published by S. Karger AG in Breast Care
- Vol. 9 (3) , 182-187
Abstract
Background: Melatonin is an endocrine hormone secreted by the pineal gland during night hours that provides several biological functions in the circadian rhythm of humans. Due to anti-estrogenic properties, melatonin is considered to exhibit a protective role against the development of breast cancer (BC). Moreover, disruption of melatonin production through environmental influences, such as night work, is assumed to be a risk factor for BC. Materials and Methods: We reviewed recent findings concerning biological effects of melatonin on BC and conducted a meta-analysis to evaluate the association between melatonin and BC incidence. In random and fixed effects statistical models, concentrations (tertiles, quartiles) of the primary urinary metabolite of melatonin, 6-sulfatoxymelatonin (aMT6s), were tested for the assumption that women with the highest values would exhibit a lower risk of BC. Results: Statistical analysis of data from 5 prospective case-control studies indicates an inverse association between BC risk and the highest levels of urinary aMT6s. This effect seems to be influenced by lag intervals between aMT6s collection and the occurrence of BC, timing and methods of urine sampling, as well as genetic and environmental factors. Conclusion: On the basis of the results of our meta-analysis, melatonin is likely to affect BC occurrence in women. However, methodological dissonances may require further studies.Keywords
This publication has 61 references indexed in Scilit:
- Circadian Disruption, Sleep Loss, and Prostate Cancer Risk: A Systematic Review of Epidemiologic StudiesCancer Epidemiology, Biomarkers & Prevention, 2012
- Sleep duration, spot urinary 6‐sulfatoxymelatonin levels and risk of breast cancer among Chinese women in SingaporeInternational Journal of Cancer, 2012
- Night-Shift Work and Breast Cancer Risk in a Cohort of Chinese WomenAmerican Journal of Epidemiology, 2010
- Urinary 6-Sulphatoxymelatonin Levels and Risk of Breast Cancer in Premenopausal Women: The ORDET CohortCancer Epidemiology, Biomarkers & Prevention, 2010
- Use of Transdermal Melatonin Delivery to Improve Sleep Maintenance During DaytimeClinical Pharmacology & Therapeutics, 2009
- Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study CohortCancer Epidemiology, Biomarkers & Prevention, 2009
- Sleep duration and the risk of breast cancer: the Ohsaki Cohort StudyBritish Journal of Cancer, 2008
- Urinary 6-Sulfatoxymelatonin Levels and Risk of Breast Cancer in Postmenopausal WomenJNCI: Journal of the National Cancer Institute, 2008
- Sleep duration, melatonin and breast cancer among Chinese women in SingaporeCarcinogenesis, 2008
- Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activityInternational Journal of Cancer, 2005